Biosensing platforms are rapid and convenient methods for trace amount detection
of biological molecules or drugs. By implementing user-designed and user-controlled
biosensors, this could allow for rapid response clinical strategies design, while
also identifying toxicity, treatment doses options or inhibitor binding. Implantable
biosensor platforms could delineate in real time conditions system response, with
limited costs of operation and implementation.
Affiliated Faculty
Recent Publications
- Hu, X., Dinu, C.Z., "Nanoporous gold electrode for ultrasensitive detection of neurotoxin fasciculin", Analytica Chimica Acta (2019) 1085: 91-97.
- Bonciu, A., Wagner, A., Marascu, V., Moldovan, A., Dinu*, C.Z., and Dinca*, V., "Influence of laser-designed microstructures density on interfaces characteristics and on preliminary responses of epithelial cells", Applied Sciences , in press (2020).
- Eldawud, R., Wagner, A., Dong, Gupta, N., Rojanasakul, Y., O’Doherty, G., Stueckle, T., Dinu, C.Z., "Digitoxin and user-designed analog cause transformation of human lung cancer cells to a benign phenotype", BBA - General Subjects, in press (2020).